Orforglipron (Oral GLP-1 Research Compound)

Why a non-peptide agonist is unusual

GLP-1R is a class B G-protein-coupled receptor, a family whose large extracellular domain normally requires a long peptide ligand to engage. Finding drug-like molecules that activate such receptors has been a long-standing medicinal-chemistry problem, and orforglipron belongs to the small group of compounds reported to do so at the transmembrane core rather than by mimicking the full peptide-binding interaction. Structural work on small-molecule GLP-1R agonists has described a binding pocket distinct from the orthosteric peptide site.

Signalling bias

• Preferential activation of the Gs/cAMP arm compared with β-arrestin recruitment
• Reduced receptor internalisation reported for biased agonists relative to full peptide agonists

Whether biased signalling changes downstream outcomes remains an open research question, and it is one of the reasons the compound is used as a pharmacological probe alongside peptide agonists.

Metabolic endpoints examined

Interpretation and controls

Keep the bottle closed at room temperature, away from light, heat and humidity, and leave the desiccant in place; capsules absorb moisture readily once the seal is broken. Note the lot number and the date of first opening on the bottle so results stay traceable to the Certificate of Analysis. Where a study requires solution work, open capsules only inside appropriate containment and record the exact solvent and preparation method, since the compound's solubility differs markedly from that of peptide GLP-1 analogues. Handle, label and dispose of the material under your institution's chemical hygiene plan.